Aesthetics Journal

February 2019


PROFHILO® is based on IBSA’s patented technology of stable hybrid cooperative complexes of hyaluronic acid of high and low molecular weights. It is the first BDDE-free stabilised injectable, with the highest concentration of hyaluronic acid on the market (64mg/2ml). It not only boosts and hydrates the skin, but also remodels ageing and sagging tissue. PROFHILO delivers great results as a treatment on its own or in combination with other aesthetic treatments.

Dr Preema Vig says “PROFHILO® is an excellent ‘skin treatment’ and I have now incorporated it within my injectable portfolio as the first step towards skin rejuvenation. The treatment training is invaluable to maximise the treatment outcome. It fits nicely into an aesthetic practice as a two-step treatment taking place 30 days apart with a follow-up. It is easy to understand – for the practitioner and also for the patient as it stimulates the dermal activity after the second treatment and my patients come back with glowing, radiant skin and an improved dermal texture.”